NSEUpdates5d ago · 1 Sept 2026, 04:36 pm

Updates

Symbiotec Pharmalab Limited · SYMBIOTEC

✦ AI SummaryMgmt Change

Symbiotec Pharmalab Limited has informed the Exchange regarding the authorization of Key Managerial Personnel to determine materiality of events or information and make disclosures to the stock exchange.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Symbiotec Pharmalab Limited has informed the Exchange regarding 'Disclosure under Regulation 30(5) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulation, 2015'.

Attachments (1)

📄

SYMBIOTEC_01092026163543_Reg_30_5_.pdf

pdf

Download →
View document text
Date: September 01, 2026 Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, C-1, Block G Mumbai - 400001. Bandra -Kurla Complex, Bandra (East), Mumbai- 400051. Scrip Code: 544889 Scrip Symbol : SYMBIOTEC ISIN: INE899I01028 ISIN: INE899I01028 Subject: Intimation under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Authorization for Determining Materiality of Events or Information. Dear Sir/Madam, Pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (‘Listing Regulations’), the following Key Managerial Personnel of the Company are authorized to determine materiality of an event or information and for the purpose of making disclosures to the stock exchange(s): S. No Name & Designation Contact Details 1. Anil Satwani (The Chairman & Address: Managing Director) 385/2, Pigdamber, Rau, Mhow, 2. Raghavender Ramachandran (Chief Indore – 453 331, Madhya Financial Officer) Pradesh, India 3. Salil Jain (the Company Secretary and Phone: 7316676405 Compliance Officer) Email: secretarial@symbiotec.com This is for your information and record. Thanking You, For SYMBIOTEC PHARMALAB LIMITED Salil Jain Company Secretary and Compliance Officer Membership No. A41610 Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293